Australia Diabetes Market Analysis Report by Renub Research

Australia ranked seventh in the world for the prevalence of type 1 diabetes in children and 6th highest for incidence. There is also rising prevalence of particularly type 2 diabetes and rising cases of children and adolescents who are now impated by type 2 diabetes in Australia. Type 1diabetes typically happens in an early age, its a most common form of childhood diabetes although it can occur at any age. Over 1 million Australians have been diagnosed with diabetes. Australia is dragging behind many western countries in providing affordable access to its people with diabetes to new, proven technologies such as CGM and Insulin pen that can significantly improve the management of diabetes. Australia Diabetes Market is expected to reach USD 2.44 Billion by the year 2025.

Australia Diabetes Market is expected to reach USD 2.44 Billion by the year 2025.

The market of Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring (CGM) Device, Insulin Pump, and Insulin Pen are growing due to the rising awareness for diabetes in Australia. Diabetes care in Australia has reached a high level of quality, but there is still an opportunity for further improvement. Diabetes is associated with an uncountable of complications that affect the eyes, feet, kidneys, and cardiovascular health. Besides, diabetes is ranked in the top 10 leading causes of deaths in Australia. Diabetes is a massive challenge to the nation’s health and economy.

Australian Government has essential roles in maintaining access to affordable, high-quality devices and services to support people with diabetes in self-management and treatment. The Australian Government providing support to people with diabetes through the National Diabetes Services Scheme, the Pharmaceutical Benefits Scheme, the Insulin Pump Program, and Medicare. In 2019, Biocon and Mylan N V launched insulin glargine biosimilar Semglee, first insulin PBS in Australia. In 2019, TAL, a leading Australian life insurance specialist, has launched a specialized product to protect people with diabetes mellitus in Australia.

Renub Research report titled “Australia Diabetes Market & Forecast, By Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement), Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pump Analysis- (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies), Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Companies (Eli Lilly and Company, B. Braun Melsungen AG, Ypsomed AG, Artsana S.p.A, BD, Novo Nordisk A/S, Medtronic, Insulet Corporation, Owen Mumford Ltd, LifeScan Inc., Dexcom Inc, Abbott Laboratories and Roche)” provides a complete analysis of Australia Insulin Delivery Devices Market.

Request a free Sample copy of the report:

Segments Market based on Devices

Continuous Glucose Monitoring (CGM)
Self Monitoring Blood Glucose (SMBG)
Insulin Pen
Insulin Pump

Australia Diabetes Sub-Segment Analysis

  1. Continuous Glucose Monitoring (CGM)
  2. Glucose Sensor Market & Forecast
  3. CGM Transmitter Market & Forecast
  4. CGM User
  5. CGM Reimbursement
  6. SMBG
  7. Test Strips Market and Forecast
  8. Lancet Market and Forecast
  9. Meter Market and Forecast
  10. Blood Glucose (SMBG) Users
  11. Blood Glucose Devices Reimbursement
  12. Insulin Pen Market
  13. Disposable Insulin Pen
  14. Reusable Insulin Pen
  15. Smart Insulin Pen
  16. Insulin Pen Needle Market
  17. Insulin Pen Users
  18. Reimbursement Policies
  19. Insulin Pump Market
  20. Insulin Pump Market
  21. Insulin Pump Users
  22. Insulin Pump Products
  23. Reimbursement Policies

All the 14 Companies Studied in the Report have been Studied from 3 Points

• Company Overview
• Recent Developments
• Financial Insight

Company Analysis

  1. B. Braun Melsungen AG
  2. Eli Lilly and Company
  3. Artsana S.p.A
  4. BD
  5. Novo Nordisk A/S
  6. Owen Mumford Ltd
  7. Ypsomed AG
  8. Medtronic
  9. Insulet Corporation
  10. LifeScan Inc.
  11. Abbott Laboratories
  12. Roche
  13. Dexcom Inc

Key Benefits of the Report

• This report provides current market estimates and forecasts for Australia Diabetic Market.
• Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
• Australia Diabetic Market – Growth Drivers and Challenges.
• Key sustainability strategies adopted by market players.

Industry Related Opportunity:

United States Diabetes Market:

Germany Diabetes Market:

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Follow on Linkedin:

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s